
Markets Rally, But Alpa Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-23 14:10:38Despite a broader market rally, Alpa Laboratories Ltd has plunged to its lowest price in 52 weeks, closing near Rs 54.56 on 23 Mar 2026. This decline comes amid a backdrop of weakening financial performance and persistent selling pressure that has pushed the stock down by nearly 49% over the past year.
Read full news article
Alpa Laboratories Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-03-17 16:00:23Alpa Laboratories Ltd has reached a new 52-week low, reflecting a sustained decline in its share price amid broader market gains. The stock’s recent performance highlights ongoing concerns within the Pharmaceuticals & Biotechnology sector, with the share price now trading below all key moving averages.
Read full news article
Alpa Laboratories Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-03-16 10:38:17Alpa Laboratories Ltd has touched a new 52-week low of Rs.54.56 today, marking a significant decline in its stock price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-03-13 10:10:14Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 March 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Alpa Laboratories Ltd Falls to 52-Week Low Amid Continued Downtrend
2026-03-11 16:00:11Alpa Laboratories Ltd has reached a new 52-week low, reflecting ongoing pressures in its share price as it closed at Rs 62.85, marking a significant decline from its peak of Rs 120.5 over the past year. This development underscores the challenges faced by the company within the Pharmaceuticals & Biotechnology sector amid a broader market downturn.
Read full news article
Alpa Laboratories Ltd Stock Falls to 52-Week Low of Rs.55.1
2026-03-04 10:56:55Alpa Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.55.1 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.
Read full news article
Alpa Laboratories Ltd Stock Falls to 52-Week Low of Rs.55.1
2026-03-04 10:56:52Alpa Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.55.1 today, marking a significant decline in its stock price amid ongoing underperformance relative to broader market indices and sector peers.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-03-02 10:10:21Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Alpa Laboratories Ltd is Rated Strong Sell
2026-02-19 10:10:26Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleClosure of Trading Window
20-Mar-2026 | Source : BSEThe trading Window of the company shall remain closed w.e.f 01st April 2026 till 48 hours after the declaration of the Financial results by the company for the fourth quarter and financial year ending 31st March2026.
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011
09-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
09-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Shah
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






